Skip to main content

Resultados relacionados

Resultados totales (Incluyendo duplicados): 22
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Triazolopyrimidines Are Microtubule-Stabilizing Agents that Bind the Vinca Inhibitor Site of Tubulin, Triazolopyrimidines stabilize microtubules by binding to the vinca inhibitor site of tubulin

  • Sáez-Calvo, Gonzalo
  • Balaguer, Francisco de Asís
  • Barasoain, Isabel
  • Rodríguez-Salarichs, Javier
  • Muñoz-Hernández, Hugo
  • Berbís, Manuel Álvaro
  • Peñalva, Miguel Ángel
  • Matesanz, Ruth
  • Canales, Ángeles
  • Jiménez-Barbero, Jesús
  • Andreu, José Manuel
  • Díaz, José Fernando
53 p.-7 fig.+ 7 p.-1 tab.supl.-6 fig.supl. Saez Calvo, Gonzalo et al., Microtubule-targeting agents (MTAs) are some of the clinically most successful anti-cancer drugs. Unfortunately, instances of multidrug resistances to MTA have been reported, which highlights the need for developing MTAs with different mechanistic properties. One less explored class of MTAs are [1,2,4]triazolo[1,5-a]pyrimidines (TPs). These cytotoxic compounds are microtubule-stabilizing agents that inexplicably bind to vinblastine binding site on tubulin, which is typically targeted by microtubule-destabilizing agents. Here we used cellular, biochemical, and structural biology approaches to address this apparent discrepancy. Our results establish TPs as vinca-site microtubule-stabilizing agents that promote longitudinal tubulin contacts in microtubules, in contrast to classical microtubule-stabilizing agents that primarily promote lateral contacts. Additionally we observe that TPs studied here are not affected by p-glycoprotein overexpression, and suggest that TPs are promising ligands against multidrug-resistant cancer cells., This work was supported in part by grants BFU2016‐75319‐R (AEI/FEDER, UE) (JFD), BFU2014‐51823‐R (to JMA) from Ministerio de Economia y Competitividad and 31003A_166608 from the Swiss National Science Foundation (M.O.S.). The authors acknowledge networking contribution by the COST Action CM1407 “Challenging organic syntheses inspired by nature ‐ from natural products chemistry to drug discovery”. The SAXS experiments were performed at BL11‐NCD beamline at ALBA Synchrotron with the collaboration of ALBA staff. X‐ray data were collected at beamline X06DA of the Swiss Light Source (Paul Scherrer Institut, Villigen, Switzerland)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Identification of pyrrolopyrimidine derivative PP-13 as a novel microtubule-destabilizing agent with promising anticancer properties

  • Gilson, Pauline
  • Josa-Prado, Fernando
  • Díaz, José Fernando
  • Busser, Benoit
14 p.-6 fig-.1 tab. Gilson, Pauline et al., Despite the emergence of targeted therapies and immunotherapy, chemotherapy remains the gold-standard for the treatment of most patients with solid malignancies. Spindle poisons that interfere with microtubule dynamics are commonly used in chemotherapy drug combinations. However, their troublesome side effects and the emergence of chemoresistance highlight the need for identifying alternative agents. We performed a high throughput cell-based screening and selected a pyrrolopyrimidine molecule (named PP-13). In the present study, we evaluated its anticancer properties in vitro and in vivo. We showed that PP-13 exerted cytotoxic effects on various cancer cells, including those resistant to current targeted therapies and chemotherapies. PP-13 induced a transient mitotic blockade by interfering with both mitotic spindle organization and microtubule dynamics and finally led to mitotic slippage, aneuploidy and direct apoptotic death. PP-13 was identified as a microtubule-targeting agent that binds directly to the colchicine site in β-tubulin. Interestingly, PP-13 overcame the multidrug-resistant cancer cell phenotype and significantly reduced tumour growth and metastatic invasiveness without any noticeable toxicity for the chicken embryo in vivo. Overall, PP-13 appears to be a novel synthetic microtubule inhibitor with interesting anticancer properties and could be further investigated as a potent alternative for the management of malignancies including chemoresistant ones., This work was supported by the Institut Curie, the CNRS, the INSERM, and by grants from La Fondation de France, La Ligue contre le Cancer (comité de l’Isère), Cancéropôle CLARA (Lyon Auvergne Rhône-Alpes),and BFU2016–75319-R (AEI/FEDER, UE) from Ministerio de Economia y Competitividad (JFD)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Zampanolide binding to tubulin indicates crosstalk of taxane site with colchicine and nucleotide sites

  • Field, Jessica J.
  • Pera, Benet
  • Estévez-Gallego, Juan
  • Rodríguez-Salarichs, Javier
  • Sáez-Calvo, Gonzalo
  • Andreu, José Manuel
  • Díaz, José Fernando
41 p.-8 fig.-2 tab. Field, Jessica J. et al., The marine natural product zampanolide and analogues thereof constitute a new chemotype of taxoid site microtubule-stabilizing agents with a covalent mechanism of action. Zampanolide-ligated tubulin has the switch-activation loop (M-loop) in the assembly prone form and, thus, represents an assembly activated state of the protein. In this study, we have characterized the biochemical properties of the covalently modified, activated tubulin dimer, and we have determined the effect of zampanolide on tubulin association and the binding of tubulin ligands at other binding sites. Tubulin activation by zampanolide does not affect its longitudinal oligomerization but does alter its lateral association properties. The covalent binding of zampanolide to β-tubulin affects both the colchicine site, causing a change of the quantum yield of the bound ligand, and the exchangeable nucleotide binding site, reducing the affinity for the nucleotide. While these global effects do not change the binding affinity of 2-methoxy-5-(2,3,4-trimethoxyphenyl)-2,4,6-cycloheptatrien-1-one (MTC) (a reversible binder of the colchicine site), the binding affinity of a fluorescent analogue of GTP (Mant-GTP) at the nucleotide E-site is reduced from 12 ± 2 × 105 M-1 in the case of unmodified tubulin to 1.4 ± 0.3 × 105 M-1 in the case of the zampanolide tubulin adduct, indicating signal transmission between the taxane site and the colchicine and nucleotide sites of β-tubulin., This work was supported in part by grants BFU2016-75319-R (AEI/FEDER, UE) from Ministerio de Economia y Competitividad and the Cancer Society of New Zealand, and the Wellington Medical Research Foundation (JJF & JHM). The authors acknowledge networking contribution by the COST Action CM1407 “Challenging organic syntheses inspired by nature - from natural products chemistry to drug discovery”. The CNIC is supported by the Ministerio de Ciencia e Innovación and the Fundación Pro CNIC., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Self-organization of FtsZ polymers in solution reveals spacer role of the disordered C-terminal tail, FtsZ polymers by SAXS and cryo-EM

  • Huecas, Sonia
  • Ramírez-Aportela, Erney
  • Vergoñós, Albert
  • Núñez-Ramírez, Rafael
  • Llorca, Óscar
  • Díaz, José Fernando
  • Juan-Rodríguez, David
  • Oliva, María A.
  • Castellen, Patricia
  • Andreu, José Manuel
32 p.-6 fig.+ 26 p. mat.supl., FtsZ is a self-assembling GTPase that forms, below the inner membrane, the mid-cell Z-ring guiding bacterial division. FtsZ monomers polymerize head to tail forming tubulin-like dynamic protofilaments, whose organization in the Z-ring is an unresolved problem. Rather than forming a well-defined structure, FtsZ protofilaments laterally associate in vitro into polymorphic condensates typically imaged on surfaces. We describe here nanoscale self-organizing properties of FtsZ assemblies in solution that underlie Z-ring assembly, employing time-resolved X-ray scattering (SAXS) and cryo-electron microscopy (cryo-EM). We find that FtsZ forms bundles made of loosely bound filaments of variable length and curvature. Individual FtsZ protofilaments further bend upon nucleotide hydrolysis, highlighted by the observation of some large circular structures with 2.5⁰ - 5⁰ curvature angles between subunits, followed by disassembly end-products consisting of highly curved oligomers and 16 subunit - 220 Å diameter mini-rings, here observed by cryo-EM. Neighbor FtsZ filaments in bundles are laterally spaced 70 Å, leaving a gap in between. In contrast, close contact between filament core structures (~50 Å spacing) is observed in straight polymers of FtsZ constructs lacking the C-terminal tail, which is known to provide a flexible tether essential for FtsZ functions in cell division. Changing the length of the intrinsically disordered C-tail linker modifies the inter-filament spacing. We propose that the linker prevents dynamic FtsZ protofilaments in bundles from sticking to one another, holding them apart at a distance similar to the lateral spacing observed by electron cryotomography in several bacteria and liposomes. According to this model, weak interactions between curved polar FtsZ protofilaments through their the C-tails may facilitate the coherent treadmilling dynamics of membrane-associated FtsZ bundles in reconstituted systems, as well as the recently discovered movement of FtsZ clusters around bacterial Z-rings that is powered by GTP hydrolysis and guides correct septal cell wall synthesis and cell division., This work was supported by grants MINECO BFU2014-51823-R (JMA), SAF2014-52301-R (OL), BFU2016-75319-R (JFD), EMBO fellowship ALTF-171-2005 (MAO), FAPESP grant 13/26897-7 (BEPE) and 10/51870-7 (PC), doctoral contracts CSIC-JAE (ERA) and FPI (AV)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

A fluorescence anisotropy assay to discover and characterize ligands targeting the maytansine site of tubulin

  • Menchon, Grégory
  • Lucena-Agell, Daniel
  • Díaz, José Fernando
  • Steinmetz, Michel O.
9 p.-5 fig.-1 tab. Menchon, Gregory et al., Microtubule-targeting agents (MTAs) like taxol and vinblastine are among the most successful chemotherapeutic drugs against cancer. Here, we describe a fluorescence anisotropy-based assay that specifically probes for ligands targeting the recently discovered maytansine site of tubulin. Using this assay, we have determined the dissociation constants of known maytansine site ligands, including the pharmacologically active degradation product of the clinical antibody-drug conjugate trastuzumab emtansine. In addition, we discovered that the two natural products spongistatin-1 and disorazole Z with established cellular potency bind to the maytansine site on β-tubulin. The high-resolution crystal structures of spongistatin-1 and disorazole Z in complex with tubulin allowed the definition of an additional sub-site adjacent to the pocket shared by all maytansine-site ligands, which could be exploitable as a distinct, separate target site for small molecules. Our study provides a basis for the discovery and development of next-generation MTAs for the treatment of cancer., This work was supported by grants from MINECO/FEDER (BFU2016-75319-R; to J.F.D), the Swiss National Science Foundation (31003A_166608; to M.O.S.) and by the COST Action CM1407 (to J.F.D., K.-H.A. and M.O.S.)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

High-affinity ligands of the colchicine domain in tubulin based on a structure-guided design

  • Bueno, Oskia
  • Estévez-Gallego, Juan
  • Martins, S.
  • Prota, Andrea E.
  • Gago, Federico
  • Gómez-SanJuan, Asier
  • Camarasa Rius, María José
  • Barasoain, Isabel
  • Steinmetz, Michel O.
  • Díaz, José Fernando
  • Peréz-Pérez, María-Jesús
  • Liekens, Sandra
  • Priego, Eva María
Microtubule-targeting agents that bind at the colchicine-site of tubulin are of particular interest in antitumoral therapy due to their dual mechanism of action as antimitotics and vascular disrupting agents. Cyclohexanediones derivatives have been described as a new family of colchicine-domain binders with an association constant to tubulin similar to that of colchicine. Here, the highresolution structures of tubulin in complex with cyclohexanediones TUB015 and TUB075 were solved by X-ray crystallography. A detailed analysis of the tubulin-TUB075 interaction by means of computational affinity maps allowed the identification of two additional regions at the binding site that were addressed with the design and synthesis of a new series of cyclohexanediones with a distal 2-substituted benzofurane. These new compounds showed potent antiproliferative activity with IC50 values in the nM range, arrested cell cycle progression at the G2/M phase and induced apoptosis at sub μM concentrations. Moreover, they caused the destruction of a preformed vascular network in vitro and inhibited the migration of endothelial cells at non-toxic concentrations. Finally, these compounds displayed high affinity for tubulin as substantiated by a Kb value of 2.87 × 108 M−1 which, to the best of our knowledge, represents the highest binding constant measured to date for a colchicine-domain ligand., This project has been supported by the Spanish Ministerio de Economía y Competitividad (SAF2015–64629- C2-1-R to EMP, MJPP. and MJC and SAF2015-64629-C2-2 to F.G.), by the Swiss National Science Foundation (31003A_166608, to MOS) and COST action CM1407 (to MJPP, SL, AP, MS, and JFD). We acknowledge Lizette Van Berckelaer, Eef Meyen and Sam Noppen for excellent technical assistance. We thank V. Olieric and M. Wang for excellent technical assistance with the collection of X-ray data at beamline X06SA of the Swiss Light Source (Paul Scherrer Institut, Villigen PSI, Switzerland). We thank José Fernando Escolar for his help with electron microscopy. We thank ganadería Fernando Díaz for calf brains for tubulin purification. This work was supported in part by grants BFU2016-75319-R (AEI/FEDER, UE) (JFD.) JFD. is a member of the CIB Intramural Program “Molecular Machines for Better Life” (MACBET). We also thank SEQT for the “Ramón Madroñero Award” to O.B., Peer Reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Conformational mimetics of the α-methyl chalcone TUB091 binding tubulin: Design, synthesis and antiproliferative activity

  • Bueno, Oskia
  • Tobajas, Gloria
  • Quesada, Ernesto
  • Estévez-Gallego, Juan
  • Noppen, Sam
  • Camarasa Rius, María José
  • Díaz, José Fernando
  • Liekens, Sandra
  • Priego, Eva María
  • Peréz-Pérez, María-Jesús
Based on the conformation of the α-methyl chalcone TUB091 in its complex with tubulin, a series of conformational mimetics have been designed and synthesized where the methyl group of the chalcone has been fused to phenyl ring B resulting in 1,2,3,4-tetrahydronaphthalen-2-yl aryl ketones. Among the synthesized compounds, the 5-amino-6-methoxy derivative, with a similar substitution pattern to that of TUB091, showed antiproliferative activity around 20 nM against tumor and endothelial cells. Tubulin binding experiments confirmed its binding to tubulin at the colchicine site with a Kb of 2.4 × 10 M resulting in the inhibition of the in vitro assembly of purified tubulin. Moreover, based on the recently reported complex of combretastatin A4 (CA4) with tubulin, a comparative analysis of the binding mode of CA4 and the α-methyl chalcone to tubulin has been performed., This project has been supported by MINECO (SAF2012-39760- C02-01) and MINECO/FEDER (SAF2015-64629-C2-1-R), and to M.- J.P.-P., E.-M.P. E. Q. and M. J. C. and MINECO/FEDER BFU2016- 75319-R to J.F.D. The authors acknowledge networking contribution by the COST Action CM1407 “Challenging organic syntheses inspired by nature - from natural products chemistry to drug discovery” (to M-J. P.-P. S.L. and J.-F.D.) We also would like to acknowledge Eef Meyen and Lizette Van Berckelaer for excellent technical assistance., Peer Reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Klebsiella oxytoca enterotoxins tilimycin and tilivalline have distinct host DNA-damaging and microtubulestabilizing activities

  • Unterhauser, Katrin
  • Poltl, Lisa
  • Schneditz, Georg
  • Kienesberger, Sabine
  • Glabonjat, Ronald A.
  • Kitsera, Maksym
  • Pletz, Jakob
  • Josa-Prado, Fernando
  • Dornisch, Elisabeth
  • Lembacher-Fadum, Christian
  • Roier, Sandro
  • Gorkiewicz, Gregor
  • Lucena-Agell, Daniel
  • Barasoain, Isabel
  • Kroutil, Wolfgang
  • Wiedner, Marc
  • Loizou, Joanna I.
  • Breinbauer, Rolf
  • Díaz, José Fernando
  • Schild, Stefan
  • Hog̈enauer, Christoph
  • Zechner, Ellen L.
10 p.-6 fig., Establishing causal links between bacterial metabolites and human intestinal disease is a significant challenge. This study reveals the molecular basis of antibiotic-associated hemorrhagic colitis (AAHC) caused by intestinal resident Klebsiella oxytoca Colitogenic strains produce the nonribosomal peptides tilivalline and tilimycin. Here, we verify that these enterotoxins are present in the human intestine during active colitis and determine their concentrations in a murine disease model. Although both toxins share a pyrrolobenzodiazepine structure, they have distinct molecular targets. Tilimycin acts as a genotoxin. Its interaction with DNA activates damage repair mechanisms in cultured cells and causes DNA strand breakage and an increased lesion burden in cecal enterocytes of colonized mice. In contrast, tilivalline binds tubulin and stabilizes microtubules leading to mitotic arrest. To our knowledge, this activity is unique for microbiota-derived metabolites of the human intestine. The capacity of both toxins to induce apoptosis in intestinal epithelial cells-a hallmark feature of AAHC-by independent modes of action, strengthens our proposal that these metabolites act collectively in the pathogenicity of colitis., We acknowledge networking contributions from European Cooperation in Science and Technology Action CM1407, “Challenging Organic Syntheses Inspired by Nature—From Natural Products Chemistry to Drug Discovery.” Research was funded by the Austrian Science Fund W901 Doktoratskolleg Molecular Enzymology (to E.L.Z., S.S., W.K., and R.B.), BioTechMed-Graz Secretome Flagship (to S.S., E.L.Z., G.G., C.H., and R.B.), and Grant BFU2016-75319-R (Agencia Española de Investigacion/Fondo Europeo de desarrollo regional, Unión Europea) (to J.F.D.) from Ministerio de Economica y Competitividad., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Synthesis, Microtubule-Binding Affinity, and Antiproliferative Activity of New Epothilone Analogs and of an EGFR-Targeted Epothilone-Peptide Conjugate

  • Gaugaz, Fabienne Z.
  • Chicca, Andrea
  • Redondo-Horcajo, Mariano
  • Barasoain, Isabel
  • Díaz, José Fernando
  • Altmann, Karl-Heinz
A new simplified, epoxide-free epothilone analog was prepared incorporating an N-(2-hydroxyethyl)-benzimidazole side chain, which binds to microtubules with high affinity and inhibits cancer cell growth in vitro with nM potency. Building on this scaffold, a disulfide-linked conjugate with the purported EGFR-binding (EGFR, epidermal growth factor receptor) peptide GE11 was then prepared. The conjugate retained significant microtubule-binding affinity, in spite of the size of the peptide attached to the benzimidazole side chain. The antiproliferative activity of the conjugate was significantly lower than for the parent scaffold and, surprisingly, was independent of the EGFR expression status of cells. Our data indicate that the disulfide-based conjugation with the GE11 peptide is not a viable approach for effective tumor-targeting of highly potent epothilones and probably not for other cytotoxics., We are indebted to the Swiss National Science Foundation (F.G.Z.; project number 205320-117594) and the ETH Zürich for generous financial support. This work was also supported by Ministerio de Economia y Competitividad grant BFU2016-75319-R to FDP (AEI/FEDER, UE). We thank Ganadería Fernando Díaz for the supply of calf brains. The authors acknowledge networking contributions by the COST Action CM1407 “Challenging organic syntheses inspired by nature - from natural products chemistry to drug discovery” and the COST action CM1470, We acknowledge support by the CSIC Open Access Publication Initiative through its Unit of Information Resources for Research (URICI), Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Diphenyl ether derivatives occupy the expanded binding site of cyclohexanedione compounds at the colchicine site in tubulin by movement of the aT5 loop

  • Bueno, Oskia
  • Gargantilla, Marta
  • Estévez-Gallego, Juan
  • Martins, Solange
  • Díaz, José Fernando
  • Camarasa Rius, María José
  • Liekens, Sandra
  • Peréz-Pérez, María-Jesús
  • Priego, Eva María
Microtubule targeting agents represent a very active arena in the development of anticancer agents. In particular, compounds binding at the colchicine site in tubulin are being deeply studied, and the structural information recently available on this binding site allows structure-directed design of new ligands. Structural comparison of our recently reported high resolution X-Ray structure of the cyclohexanedione derivative TUB075 bound to tubulin and the tubulin-DAMA-colchicine complex has revealed a conformational change in the aT5 loop. By a grid-based computational analysis of the tubulinDAMA-colchicine binding site, we have identified a new favourable binding area in the colchicine-site that was unexplored by our lead TUB075. Thus, based on a structure-guided design, new cyclohexanedione derivatives have been synthesized and tested for tubulin binding and in cellular assays. As a result, we have identified diphenyl ether derivatives with IC50 values around 10e40 nM against three different tumor cell lines and affinity constants for tubulin similar to that of colchicine around 107 M 1 . As expected, they halted the cell cycle progression at G2/M phase at concentrations as low as 0.08 mM., This project has been supported by the Spanish Ministerio de Economía y Competitividad SAF2015-64629-C2-1-R (to EMP, MJPP. and MJC) and BFU2016-75319-R (AEI/FEDER, UE) (JFD.) Financial support from CSIC (Proyecto Intramural PIE-201668E079 to MJPP) is also acknowledged. The authors acknowledge networking contribution by COST action CM1407 “Challenging synthesis inspired by nature e from natural products chemistry to drug discovery” (to MJPP, SL, and JFD). JFD. is a member of the CIB Intramural Program ‘‘Molecular Machines for Better Life’’ (MACBET). We acknowledge Lizette Van Berckelaer, Eef Meyen and Sam Noppen for excellent technical assistance. We thank ganadería Fernando Díaz for calf brains for tubulin purification., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Crystal Structure of the Cyclostreptin-Tubulin Adduct: Implications for Tubulin Activation by Taxane-Site Ligands

  • Balaguer, Francisco de Asís
  • Mühlethaler, Tobias
  • Estévez-Gallego, Juan
  • Calvo, Enrique
  • Giménez-Abián, Juan F.
  • Risinger, April L.
  • Sorensen, Erik J.
  • Vanderwal, Christopher D.
  • Altmann, Karl-Heinz
  • Mooberry, Susan
  • Steinmetz, Michel O.
  • Oliva, María A.
  • Prota, Andrea E.
  • Díaz, José Fernando
It has been proposed that one of the mechanisms of taxane-site ligand-mediated tubulin activation is modulation of the structure of a switch element (the M-loop) from a disordered form in dimeric tubulin to a folded helical structure in microtubules. Here, we used covalent taxane-site ligands, including cyclostreptin, to gain further insight into this mechanism. The crystal structure of cyclostreptin-bound tubulin reveals covalent binding to βHis229, but no stabilization of the M-loop. The capacity of cyclostreptin to induce microtubule assembly compared to other covalent taxane-site agents demonstrates that the induction of tubulin assembly is not strictly dependent on M-loop stabilization. We further demonstrate that most covalent taxane-site ligands are able to partially overcome drug resistance mediated by βIII-tubulin (βIII) overexpression in HeLa cells, and compare their activities to pironetin, an interfacial covalent inhibitor of tubulin assembly that displays invariant growth inhibition in these cells. Our findings suggest a relationship between a diminished interaction of taxane-site ligands with βIII-tubulin and βIII tubulin-mediated drug resistance. This supports the idea that overexpression of βIII increases microtubule dynamicity by counteracting the enhanced microtubule stability promoted by covalent taxane-site binding ligands., This research was funded by Ministerio de Economia y Competitividad grant BFU2016-75319-R to JFDP (both AEI/FEDER, UE); Ministerio de Ciencia e Innovación RYC-2011-07900 to MAO; Swiss National Science Foundation grant (31003A_166608) to MOS and CA121138 to SLM. The authors acknowledge networking contribution by the COST Action CM1407 “Challenging organic syntheses inspired by nature”—from natural products chemistry to drug discovery, We acknowledge support by the CSIC Open Access Publication Initiative through its Unit of Information Resources for Research (URICI), Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Synthesis, profiling, and bioactive conformation of trans-Cyclopropyl Epothilones

  • Kuzniewski, Christian N.
  • Glauser, Simon
  • Gaugaz, Fabienne Z.
  • Schiess, Raphael
  • Rodríguez-Salarichs, Javier
  • Vetterli, Stefan
  • Horlacher, Oliver P.
  • Gertsch, Jürg
  • Redondo-Horcajo, Mariano
  • Canales, Ángeles
  • Jiménez-Barbero, Jesús
  • Díaz, José Fernando
  • Altmann, Karl-Heinz
16 p.-6 fig.-2 tab., A series of new 3‐deoxy‐C(12),C(13)‐trans‐cyclopropyl‐epothilones have been prepared, bearing benzothiazole, quinoline, thiazol‐5‐ylvinyl, or isoxazol‐3‐ylvinyl side chains. For analogs with fused aromatic side chains, macrocyclic ring‐closure was based on ring‐closing olefin metathesis (RCM) of a precursor incorporating the fully elaborated heavy atom framework of the target structure (including the side chain moiety), while side chain attachment for the thiazole and isoxazole‐containing 16‐desmethyl analogs was performed only after establishment of the macrolactone core. Two approaches were elaborated for a macrocyclic aldehyde as the common precursor for the latter analogs that involved ring‐closure either by RCM or by macrolactonization. Benzothiazole‐ and quinoline‐based analogs were found to be highly potent antiproliferative agents; the two analogs with a thiazol‐5‐ylvinyl or an isoxazol‐3‐ylvinyl side chain likewise showed good antiproliferative activity but were significantly less potent than the parent epothilone A. Surprisingly, the desaturation of the C(10)−C(11) bond in these analogs was associated with a virtually complete loss in antiproliferative activity, which likely reflects a requirement for a ca. 60 ° C(10)−C(11) torsion angle in the tubulin‐bound conformation of 12,13‐trans‐epothilones., We are indebted to the Swiss National Science Foundation (F. G. Z.; project number 205320‐117594) and the ETH Zürich for generous financial support. This work was also supported by: Agencia Estatal de Investigación of Spain (grants CTQ2015‐64597‐C2‐1‐P to J. J. B., and CTQ2016‐76263P to A. C.) and Ministerio de Economia y Competitividad grant BFU2016‐75319‐R to J. F. D. P. (both AEI/FEDER, UE). The authors acknowledge networking contributions by the COST Action CM1407 ‘Challenging organic syntheses inspired by nature – from natural products chemistry to drug discovery’ and the COST action CM1470., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Identification of the guanine nucleotide exchange factor for SAR1 in the filamentous fungal model Aspergillus nidulans

  • Bravo-Plaza, Ignacio
  • Hernández-González, Miguel
  • Pinar, Mario
  • Díaz, José Fernando
  • Peñalva, Miguel Ángel
33 p.-5 fig.-3 fig. supl.-3 tab. supl., In spite of its basic and applied interest, the regulation of ER exit by filamentous fungi is insufficiently understood. In previous work we isolated a panel of conditional mutations in sarA encoding the master GTPase SarASAR1 in A. nidulans and demonstrated its key role in exocytosis and hyphal morphogenesis. However, the SAR1 guanine nucleotide exchange factor (GEF), Sec12, has not been characterized in any filamentous fungus, largely due to the fact that SEC12 homologues share little amino acid sequence identity beyond a GGGGxxxxGϕxN motif involved in guanine nucleotide exchange. Here we demonstrate that AN11127 encodes A. nidulans Sec12, which is an essential protein that localizes to the ER and that, when overexpressed, rescues the growth defect resulting from a hypomorphic sarA6ts mutation at 37 °C. Using purified, bacterially expressed proteins we demonstrate that the product of AN11127 accelerates nucleotide exchange on SarASAR1, but not on its closely related GTPase ArfAARF1, as expected for a bona fide GEF. The unequivocal characterization of A. nidulans Sec12 paves the way for the tailored modification of ER exit in a model organism that is closely related to industrial species of filamentous fungi., This work was supported by Spain's ‘Ministerio de Ciencia, Innovación y Universidades’ (MCIU/AEI/FEDER, UE) grants BIO2015-65090R and RTI2018-093344-B-I00 to M.A.P. and BFU2016-75319-R to J.F.D.; and by grant S2017/BMD-3691 InGEMICS-CM funded by the Comunidad de Madrid (Spain) and European Structural and Investment Funds., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Structural basis of colchicine-site targeting acylhydrazones active against multidrug-resistant acute lymphoblastic leukemia

  • Cury, Nathália Moreno
  • Mühlethaler, Tobias
  • Laranjeira, Angelo Brunelli Albertoni
  • Canevarolo, Rafael Renatino
  • Zenatti, Priscila Pini
  • Lucena-Agell, Daniel
  • Barasoain, Isabel
  • Song, Chunhua
  • Sun,Dongxiao
  • Dovat, Sinisa
  • Yunes, Rosendo Augusto
  • Prota, Andrea E.
  • Steinmetz, Michel O.
  • Díaz, José Fernando
  • Yunes, José Andrés
38 p.-8 fig.-2 tab.-8 fig supl.-2 tab. supl., Tubulin is one of the best validated anti-cancer targets, but most anti-tubulin agents have unfavorable therapeutic indexes. Here, we characterized the tubulin-binding activity, the mechanism of action, and the in vivo anti-leukemia efficacy of three 3,4,5-trimethoxy-N-acylhydrazones. We show that all compounds target the colchicine-binding site of tubulin and that none is a substrate of ABC transporters. The crystal structure of the tubulin-bound N-(1'-naphthyl)-3,4,5-trimethoxybenzohydrazide (12) revealed steric hindrance on the T7 loop movement of β-tubulin, thereby rendering tubulin assembly incompetent. Using dose escalation and short-term repeated dose studies, we further report that this compound class is well tolerated to >100 mg/kg in mice. We finally observed that intraperitoneally administered compound 12 significantly prolonged the overall survival of mice transplanted with both sensitive and multidrug-resistant acute lymphoblastic leukemia (ALL) cells. Taken together, this work describes promising colchicine-site-targeting tubulin inhibitors featuring favorable therapeutic effects against ALL and multidrug-resistant cells., N.M.C. was supported by a fellowship from Fundaçao de Amparo à Pesquisa do Estado de Sao Paulo (FAPESP, 14/08247-8, and 17/14737-6). J.A.Y. received a Productivity fellowship from the Brazilian National Counsel of Technological and Scientific Development (CNPq 305896/2013-0 and 301596/2017-4). This work was supported in part by grants BFU2016-75319-R (AEI/FEDER, UE) (J.F.D.) from Ministerio de Economía y Competitividad. The crystal structure work was supported by grants from the Swiss National Science Foundation (31003A_166608, to M.O.S.) and by the COST action CM1407 (toM.O.S.). Part of the in vivo work was supported by R01CA209829 and R01CA213912, Hyundai Hope OnWheels Scholar Grant, Bear Necessities Pediatric Cancer Foundation, Alex’s Lemonade Stand Foundation, the Four Diamonds Fund of the Pennsylvania State University College of Medicine, and the John Wawrynovic Leukemia Research Scholar Endowment (to S.D.)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Structure, Thermodynamics, and Kinetics of Plinabulin Binding to Two Tubulin Isotypes

  • La Sala, Giuseppina
  • Olieric, Natacha
  • Sharma, Ashwani
  • Viti, Federica
  • Balaguer, Francisco de Asís
  • Huang, Lan
  • Tonra, James R.
  • Lloyd, George Kenneth
  • Decherchi, Sergio
  • Díaz, José Fernando
  • Steinmetz, Michel O.
  • Cavalli, Andrea
25 p.-5 fig.-1 tab. + 6 fig. supl.+ 1 tab. supl., αβ-Tubulin is a validated target for anticancer drug discovery, and molecules binding to this protein are used to treat several types of tumors. Here, we report on a combined X-ray crystallography and molecular dynamics approach to study drug binding within the colchicine site of αβ-tubulin, focusing on plinabulin, an agent currently in phase 3 clinical testing for the treatment of cancer and chemotherapy-induced neutropenia. We found that plinabulin is more persistently bound to the colchicine site of βII- compared to βIII-tubulin, allowing for a prediction of isotype-expression-dependent drug sensitivity. Additionally, computational residence time and exit paths from the βII-tubulin were compared between plinabulin and two other compounds, colchicine and combretastatin-A4. The former displayed the highest residence time, followed by plinabulin and then distantly by combretastatin-A4. Our combined experimental and computational protocol could help to investigate anti-tubulin drugs, improving our understanding of their mechanism of action, residence time, and tubulin isotype selectivity., This work was financially supported by BeyondSpring Pharmaceuticals Inc. (to M.O.S. and A.C.) and by grants from the Ministerio de Ciencia Innovacion y Universidades (BFU2016-75319-R; to J.F.D.), from the Swiss National Science Foundation (31003A_166608, to M.O.S.) and from the Regione Lombardia (Accordo per la Ricerca e l’Innovazione)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Structural model for differential cap maturation at growing microtubule ends

  • Estévez-Gallego, Juan
  • Josa-Prado, Fernando
  • Ku, Siou
  • Martínez Buey, Rubén
  • Balaguer, Francisco de Asís
  • Prota, Andrea E.
  • Lucena-Agell, Daniel
  • Kamma-Lorger, C.S.
  • Yagi, Toshiki
  • Iwamoto, Hiroyuki
  • Duchesne, Laurence
  • Barasoain, Isabel
  • Steinmetz, Michel O.
  • Chrétien, Denis
  • Kamimura, Shinji
  • Díaz, José Fernando
  • Oliva, María A.
26 p.-5 fig.-5 tab., Microtubules (MTs) are hollow cylinders made of tubulin, a GTPase responsible for essential functions during cell growth and division, and thus, key target for anti-tumor drugs. In MTs, GTP hydrolysis triggers structural changes in the lattice, which are responsible for interaction with regulatory factors. The stabilizing GTP-cap is a hallmark of MTs and the mechanism of the chemical-structural link between the GTP hydrolysis site and the MT lattice is a matter of debate. We have analyzed the structure of tubulin and MTs assembled in the presence of fluoride salts that mimic the GTP-bound and GDP•Pi transition states. Our results challenge current models because tubulin does not change axial length upon GTP hydrolysis. Moreover, analysis of the structure of MTs assembled in the presence of several nucleotide analogues and of taxol allows us to propose that previously described lattice expansion could be a post-hydrolysis stage involved in Pi release., This work was supported by Ministerio de Economia y Competitividad grants BFU2013-47014-P to MAO and BFU2016-75319-R to FDP (both AEI/FEDER, UE); Ministerio de Ciencia e Innovación RYC-2011–07900 to MAO; European Union H2020-MSCA-ITN-ETN/0582 ITN TubInTrain to FDP and AEP; Swiss National Science Foundation (31003A_166608) to MOS; JSPS KAKENHI (16K07328/17H03668) to SK; (FSE) ANR-16-CE11-0017-01 to DC and LD. JE-G was supported by Ministerio de Educación, Cultura y Deporte FPU15-03140 and SK by French Ministry of Higher Education of Research and Innovation (IGDR). Cryo-EM data were adquired on the MRic platform (Univ. Rennes, CNRS, Inserm, BIOSIT-UMS 3480, US_S 018, F-35000 Rennes, France). The authors acknowledge networking contribution by the COST Action CM1407 “Challenging organic syntheses inspired by nature - from natural products chemistry to drug discovery", Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

On the Importance of the Thiazole Nitrogen in Epothilones: Semisynthesis and Microtubule-Binding Affinity of Deaza-Epothilone C

  • Edenharter, Adriana
  • Ryckewaert, Lucie
  • Cintulová, Daniela
  • Estévez-Gallego, Juan
  • Díaz, José Fernando
  • Altmann, Karl-Heinz
© 2020 by the authors., Deaza-epothilone C, which incorporates a thiophene moiety in place of the thiazole heterocycle in the natural epothilone side chain, has been prepared by semisynthesis from epothilone A, in order to assess the contribution of the thiazole nitrogen to microtubule binding. The synthesis was based on the esterification of a known epothilone A-derived carboxylic acid fragment and a fully synthetic alcohol building block incorporating the modified side chain segment and subsequent ring-closure by ring-closing olefin metathesis. The latter proceeded with unfavorable selectivity and in low yield. Distinct differences in chemical behavior were unveiled between the thiophene-derived advanced intermediates and what has been reported for the corresponding thiazole-based congeners. Compared to natural epothilone C, the free energy of binding of deaza-epothilone C to microtubules was reduced by ca. 1 kcal/mol or less, thus indicating a distinct but non-decisive role of the thiazole nitrogen in the interaction of epothilones with the tubulin/microtubule system. In contrast to natural epothilone C, deaza-epothilone C was devoid of antiproliferative activity in vitro up to a concentration of 10 μM, presumably due to an insufficient stability in the cell culture medium., This work was supported by institutional funding from ETH Zürich (A.E., K.-H.A., L.R., D.C.) and by Ministerio de Economia y Competitividad grants BFU2016-75319-R to J.F.D. (both AEI/FEDER, UE) and H2020-MSCA-ITN-2019 860070 TUBINTRAIN to J.F.D. and a donation from Club deportivo Escuela Hungaresa de Pontevedra. No funds were received to cover the costs for publication in open access., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Two antagonistic microtubule targeting drugs act synergistically to kill cancer cells

  • Peronne, Lauralie
  • Denarier, Eric
  • Rai, Ankit
  • Prudent, Renaud
  • Vernet, Audrey
  • Suzanne, Peggy
  • Ramírez-Ríos, Sacnicte
  • Michallet, Sophie
  • Guidetti, Mélanie
  • Vollaire, Julien
  • Lucena-Agell, Daniel
  • Ribba, Anne-Sophie
  • Josserand, Véronique
  • Coll, Jean-Luc
  • Dallemagne, Patrick
  • Díaz, José Fernando
  • Oliva, María A.
  • Sadoul, Karin
  • Akhmanova, Anna
  • Andrieux, Annie
  • Lafanechère, Laurence
Paclitaxel is a microtubule stabilizing agent and a successful drug for cancer chemotherapy inducing, however, adverse effects. To reduce the effective dose of paclitaxel, we searched for pharmaceutics which could potentiate its therapeutic effect. We screened a chemical library and selected Carba1, a carbazole, which exerts synergistic cytotoxic effects on tumor cells grown in vitro, when co-administrated with a low dose of paclitaxel. Carba1 targets the colchicine binding-site of tubulin and is a microtubule-destabilizing agent. Catastrophe induction by Carba1 promotes paclitaxel binding to microtubule ends, providing a mechanistic explanation of the observed synergy. The synergistic effect of Carba1 with paclitaxel on tumor cell viability was also observed in vivo in xenografted mice. Thus, a new mechanism favoring paclitaxel binding to dynamic microtubules can be transposed to in vivo mouse cancer treatments, paving the way for new therapeutic strategies combining low doses of microtubule targeting agents with opposite mechanisms of action., This work was supported by INSERM, Université Grenoble Alpes, CNRS, and by l’Institut National du Cancer (INCa, PLBIO16186), Fondation ARC (PJA 20151203348) and Association “Le Cancer du Sein, Parlons-en!”, to L.L., by Grant Ministerio de Economia y Competitividad grant BFU2016-75319-R, (AEI/FEDER, UE), European Union H2020-MSCA-ITN-ETN/0582 ITN TubInTrain to FDP, and The Netherlands Organization for Scientific Research (NWO) CW ECHO grant (711.015.005) to Anna Akhmanova The Optimal imaging platform is supported by France Life Imaging (French program “Investissement d’Avenir” grant; “Infrastructure d’avenir en Biologie Santé”, ANR-11-INBS-0006) and the IBISA French consortium “Infrastructures en Biologie Santé et Agronomie”., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Structural basis of microtubule stabilization by discodermolide

  • Prota, Andrea E.
  • Bargsten, Katja
  • Redondo-Horcajo, Mariano
  • Smith III, Amos B.
  • Yang, Chia-Ping H.
  • McDaid, Hayley M.
  • Paterson, Ian
  • Horwitz, Susan
  • Díaz, José Fernando
  • Steinmetz, Michel O.
5 p.-4 fig.-1 schem., Microtubule-stabilizing agents (MSAs) are widely used in chemotherapy. Here, using X-ray crystallography we describe the detailed binding modes of two potent MSAs, (+)-discodermolide (DDM) and the DDM-paclitaxel-hybrid KS-1-199-32, in the taxane pocket of B-tubulin. Both compounds bind in a very similar hairpin conformation as previously observed in solution. However, they differentially stabilize the M-loop of B-tubulin: KS-1-199-32 induces an M-loop helical conformation that is not observed for DDM. In the context of the microtubule structure, both MSAs connect the B-tubulin helices H6 and H7 and loop S9-S10 with the M-loop, which is similar to the structural effects elicited by epothilone A, but distinct from paclitaxel. Together, our data rationalize a differential binding mechanism of DDM and KS-1-199-32 on tubulin., This work was supported by grants from the Ministerio de Economia y Competitividad (BFU2016‐75319‐R (AEI/FEDER, UE), to J.F.D), the National Cancer Institute Grant CA077263 (A.B.S, H.M.D. and S.B.H), the Breast Cancer Research Foundation (H.M.D. and S.B.H.) and the Swiss National Science Foundation (31003A_166608; to M.O.S.). The authors acknowledge networking contribution by the COST Action CM1407 “Challenging organic syntheses inspired by nature - from natural products chemistry to drug discovery” and the COST action CM1470., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Structure-activity relationships, biological evaluation and structural studies of novel pyrrolonaphthoxazepines as antitumor agents

  • Brindisi, Margherita
  • Ulivieri, Cristina
  • Alfano, Gloria
  • Gemma, Sandra
  • Balaguer, Francisco de Asís
  • Khan, Tuhina
  • Grillo, Alessandro
  • Chemi, Giulia
  • Menchon, Grégory
  • Prota, Andrea E.
  • Olieric, Natacha
  • Lucena-Agell, Daniel
  • Barasoain, Isabel
  • Díaz, José Fernando
  • Nebbioso, Angela
  • Conte, Mariarosaria
  • Lopresti, Ludovica
  • Magnano, Stefania
  • Amet, Rebecca
  • Kinsella, Paula
  • Zisterer, Daniela M.
  • Ibrahim, Ola
  • O'Sullivan, Jeff
  • Morbidelli, Lucia
  • Spaccapelo, Roberta
  • Baldari, Cosima T.
  • Butini, Stefania
  • Novellino, Ettore
  • Campiani, Giuseppe
  • Altucci, Lucia
  • Steinmetz, Michel O.
  • Brogi, Simone
Microtubule-targeting agents (MTAs) are a class of clinically successful anti-cancer drugs. The emergence of multidrug resistance to MTAs imposes the need for developing new MTAs endowed with diverse mechanistic properties. Benzoxazepines were recently identified as a novel class of MTAs. These anticancer agents were thoroughly characterized for their antitumor activity, although, their exact mechanism of action remained elusive. Combining chemical, biochemical, cellular, bioinformatics and structural efforts we developed improved pyrrolonaphthoxazepines antitumor agents and their mode of action at the molecular level was elucidated. Compound 6j, one of the most potent analogues, was confirmed by X-ray as a colchicine-site MTA. A comprehensive structural investigation was performed for a complete elucidation of the structure-activity relationships. Selected pyrrolonaphthoxazepines were evaluated for their effects on cell cycle, apoptosis and differentiation in a variety of cancer cells, including multidrug resistant cell lines. Our results define compound 6j as a potentially useful optimized hit for the development of effective compounds for treating drug-resistant tumors., This work was supported in part by a grant from the Swiss National Science Foundation (31003A_166608; to M.O.S), grant BFU2016-75319-R (AEI/FEDER, EU) from Ministerio de Economia y Competitividad, Blueprint 282510, AIRC-17217. The authors acknowledge networking contribution by the COST Action CM1407 “Challenging organic syntheses inspired by nature - from natural products chemistry to drug discovery” (to M.O.S. and J.F.D.) and the COST Action EPICHEMBIO CM-1406 (to L.A. and G.C.). This work has also received partial funding from the European Union’s Horizon 2020 (EU) research and innovation programme under the Marie Sklodowska-Curie grant agreement No 721906. Finally, this work was partially funded by MIUR-PRIN project n. 2015Y3C5KP (to L.M.).
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Quinolin-6-yloxyacetamides are microtubule destabilizing agents that bind to the colchicine site of tubulin

  • Sharma, Ashwani
  • Sáez-Calvo, Gonzalo
  • Olieric, Natacha
  • Balaguer, Francisco de Asís
  • Barasoain, Isabel
  • Lamberth, Clemens
  • Díaz, José Fernando
  • Steinmetz, Michel O.
Quinolin-6-yloxyacetamides (QAs) are a chemical class of tubulin polymerization inhibitors that were initially identified as fungicides. Here, we report that QAs are potent anti-proliferative agents against human cancer cells including ones that are drug-resistant. QAs act by disrupting the microtubule cytoskeleton and by causing severe mitotic defects. We further demonstrate that QAs inhibit tubulin polymerization in vitro. The high resolution crystal structure of the tubulin-QA complex revealed that QAs bind to the colchicine site on tubulin, which is targeted by microtubule-destabilizing agents such as colchicine and nocodazole. Together, our data establish QAs as colchicine-site ligands and explain the molecular mechanism of microtubule destabilization by this class of compounds. They further extend our structural knowledge on antitubulin agents and thus should aid in the development of new strategies for the rational design of ligands against multidrug-resistant cancer cells., This work was supported by grants from Spanish Ministerio de Economía y Competitividad (BFU2016-75319-R (AEI/FEDER, UE) to J. Fernando Díaz) and from the Swiss National Science Foundation (31003A_166608 to Michel O. Steinmetz). The authors acknowledge networking contribution by the COST (European Cooperation in Science and Technology) Action CM1407 “Challenging organic syntheses inspired by nature—from natural products chemistry to drug discovery”. X-ray data were collected at beamline X06DA of the Swiss Light Source (Paul Scherrer Institut, Villigen, Switzerland). Ashwani Sharma was supported by an EMBO (European Molecular Biology Organization) Long Term Fellowship, J. Fernando Díaz is member of the CIB Intramural Program “Molecular Machines for Better Life” (MACBET).
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

CLIP-170S is a microtubule +TIP variant that confers resistance to taxanes by impairing drug-target engagement

  • Thakkar, Prashant V.
  • Kita, Katsuhiro
  • Del Castillo, Urko
  • Galletti, Giuseppe
  • Madhukar, Neel
  • Vila Navarro, Elena
  • Barasoain, Isabel
  • Goodson, Holly V.
  • Sackett, Dan L.
  • Díaz, José Fernando
  • Lu, Yao
  • RoyChoudhary, Arindam
  • Molina, Henrik
  • Elemento, Olivier
  • Shah, Manish A.
  • Giannakakou, Paraskevi
73 p.-5 fig.-1 tab.-11 fig supl.-2 vid. supl., Taxanes are widely used cancer chemotherapeutics. However, intrinsic resistance limits their efficacy without any actionable resistance mechanism. We have discovered a microtubule (MT) plus-end-binding CLIP-170 protein variant, hereafter CLIP-170S, which we found enriched in taxane-resistant cell lines and patient samples. CLIP-170S lacks the first Cap-Gly motif, forms longer comets, and impairs taxane access to its MT luminal binding site. CLIP-170S knockdown reversed taxane resistance in cells and xenografts, whereas its re-expression led to resistance, suggesting causation. Using a computational approach in conjunction with the connectivity map, we unexpectedly discovered that Imatinib was predicted to reverse CLIP-170S-mediated taxane resistance. Indeed, Imatinib treatment selectively depleted CLIP-170S, thus completely reversing taxane resistance. Other RTK inhibitors also depleted CLIP-170S, suggesting a class effect. Herein, we identify CLIP-170S as a clinically prevalent variant that confers taxane resistance, whereas the discovery of Imatinib as a CLIP-170S inhibitor provides novel therapeutic opportunities for future trials., This work was supported in part by the NIH T32 training grant 5T32CA062948 (to K.K.), the NIH T32 training grant 5T32CA062948 (to G.G.), the NIH T32 training grant 5T32CA203702 (to U.D.C.) by Clinical and Translational Science Center at Weill Cornell Medicine NIH/NCATS grant ULTR00457 (to G.G.), the NIH/NCI R01CA228512 (to P.G., M.A.S., and O.E.), NIH/NCI R21 CA216800 (to P.G.), NIH/NCI R01 CA179100 (to P.G.), DoD PC180637 (P.G., A.R.C.), and by the Ministerio de Economía y Competitividad grant BFU2016-75319-R and European Union H2020-MSCA-ITN-ETN/0582 ITN TUBINTRAIN (awarded to J.F.D.). D.S. was supported by the Intramural Research Program of the Eunice Kennedy Shriver National Institute of Child Health and Human Development, NIH. Y.L. and M.A.S. were supported, in part, by funds from the Clinical and Translational Science Center (CTSC), National Center for Advancing Translational Sciences (NCATS) of the National Institutes of Health, award # UL1-TR002384-01., Peer reviewed